There would be far fewer financial returns ... if [a generic] is approved by FDA, prevent launch of generic versions of Vascepa in the US.” ...

Prescription drugs like Vascepa are generally covered by Medicare Part D, but whether your specific plan covers this drug or its generic version depends on your specific plan in your area.

The panel unanimously backed approval of Vascepa (icosapent ethyl ... and catapult the drug into multibillion-dollar territory. “There is no doubt this is a medication that could benefit ...

Last year, the U.S. Supreme Court declined to hear Amarin’s appeal of a patent loss around Vascepa, handing a win to generic drugmakers Hikma Pharmaceuticals PLC and Dr. Reddy’s Laboratories ...

Vascepa (icosapent ethyl) is used to help lower blood triglyceride levels and reduce the risk of heart problems. Medicare Part D generally covers it.